Lifecore Biomedical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LFCR research report →
About the company
Lifecore Biomedical, Inc. , together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.
- CEO
- Paul Josephs
- IPO
- 1996
- Employees
- 403
- HQ
- Chaska, MN, US
Price Chart
- Market Cap
- $190.92M
- P/E
- -4.96
- P/S
- 1.41
- P/B
- 9.18
- EV/EBITDA
- -311.85
- Div Yield
- 0.00%
- Gross Margin
- 31.17%
- Op Margin
- -0.06%
- Net Margin
- -25.22%
- ROE
- -176.12%
- ROIC
- -0.04%
- Revenue
- $128.87M · 0.00%
- Net Income
- $-38,717,000 · 0.00%
- EPS
- $-1.27 · 0.00%
- Op Income
- $-17,245,000
- FCF YoY
- 0.00%
- 52W High
- $8.98
- 52W Low
- $3.63
- 50D MA
- $5.13
- 200D MA
- $6.50
- Beta
- 1.06
- Avg Volume
- 248.13K
Get TickerSpark's AI analysis on LFCR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 26 | Kiper Christopher S | other | 25,907 |
| Jun 4, 26 | OBUS NELSON | other | 25,907 |
| Jun 4, 26 | Aryeh Jason | other | 25,907 |
| Jun 4, 26 | Schechter Joshua | other | 25,907 |
| Jun 4, 26 | Korenberg Matthew E | other | 25,907 |
| Jun 4, 26 | Antunes Humberto Calheiros | other | 25,907 |
| Jun 4, 26 | Johnson Paul Harold | other | 25,907 |
| Jun 4, 26 | HOUDE LOVAS KATRINA | other | 25,907 |
| May 20, 26 | Josephs Paul | other | 40,413 |
| Apr 14, 26 | Salus Thomas D. | other | 24,645 |
Our LFCR coverage
Recent articles, reports, and earnings notes.
No research on LFCR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LFCR report →Similar companies
Peers in the same neighborhood.